MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
STMN.SW stock logo

STMN.SW

Straumann Holding AG

$86.02
2.24
 (2.67%)
Exchange:  SIX
Market Cap:  13.716B
Shares Outstanding:  159.068M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Instruments & Supplies
   
CEO:  Guillaume Daniellot
Full Time Employees:  11342
Address: 
Peter Merian-Weg 12
Basel
4002
CH
Website:  https://www.straumann.com
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,411,8192,503,9002,605,000
Gross Profit1,788,4081,783,3811,787,000
EBITDA495,423726,154549,000
Operating Income410,973601,001549,000
Net Income246,072388,316358,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets3,395,3043,618,9973,817,764
Total Liabilities1,556,6981,575,2051,648,017
Total Stockholders Equity1,836,1792,040,1312,160,510
Total Debt412,353460,901650,716
Cash and Cash Equivalents410,310375,493475,426

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow503,950483,387505,415
Capital Expenditure-189,433-167,768-175,632
Free Cash Flow316,610315,619329,783
Net Income246,072459,485356,706
Net Change in Cash-285,793-34,81899,934

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)3,883,840.857Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)4,218,238.085Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)4,017,600Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)1,002,800.347Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)1,089,141.077Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)1,037,336.704Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)812,427.683Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)904,311.973Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)849,181.719Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,612,265.276Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,751,080.706Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,667,791.552Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)5.310Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)5.660Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)5.080Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)13Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)5Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
5.65
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
41.06
?Enterprise Value
 (TTM)
: 
14.905B  ?EV/FCF
 (TTM)
: 
45.34
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0.42
?ROE
 (TTM)
: 
0.17  ?ROIC
 (TTM)
: 
0.3
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.3
?P/B
 (TTM)
: 
6.77  ?Current Ratio
 (TTM)
: 
2.21

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
22.74Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate STMN Intrinsic Value

Common questions about STMN.SW valuation

Is Straumann Holding AG (STMN.SW) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Straumann Holding AG (STMN.SW) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is STMN.SW a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether STMN.SW trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is STMN.SW’s P/E ratio?

You can see STMN.SW’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for STMN.SW?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is STMN.SW a good long-term investment?

Whether STMN.SW fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

STMN.SW

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.67
MARKETSnap

Trading Metrics:

Open: 84.5   Previous Close: 83.78
Day Low: 84.38   Day High: 87.42
Year Low: 73.02   Year High: 115
Price Avg 50: 86.06   Price Avg 200: 92.91
Volume: 123008   Average Volume: 434238

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for STMN

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read